CD163 and neoplasm: In primary tumor stage I, we subclustered 1161 DCs into seven distinct subclusters, identifying subcluster 1 as activated DCs (n = 211 cells), subcluster 2 as CD163+CD14+ DCs (n = 191 cells), and subcluster 4 as pDCs (n = 145 cells) (Figure 8A).